Coronary microvascular dysfunction assessment: A comparative analysis of procedural aspects
Catheterization and Cardiovascular Interventions · 2024
DOI: 10.1002/ccd.30990 ↗Kurz gefasst
Fachartikel in der Zeitschrift Catheterization and Cardiovascular Interventions, 2024. Verfasst von Ilan Merdler und 13 weiteren Autor:innen. Beteiligte Einrichtung: Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia, USA. Hauptthemen laut MEDLINE: Myocardial Ischemia, Coronary Artery Disease, Microvascular Angina, Myocardial Infarction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: MedStar Health Research Institute.
Abstract (Originalsprache)
Background
Full adoption of coronary microvascular dysfunction (CMD) assessment faces challenges due to its invasive nature and concerns about prolonged procedure time and increased contrast and/or radiation exposure. We compared procedural aspects of CMD invasive assessment to diagnostic left heart catheterization (DLHC) in patients with chest pain who were not found to have obstructive coronary artery disease.
Methods
A total of 227 patients in the Coronary Microvascular Disease Registry were compared to 1592 patients who underwent DLHC from August 2021 to November 2023. The two cohorts were compared using propensity‐score matching; primary outcomes were fluoroscopy time and total contrast use.
Results
The participants' mean age was 64.1 ± 12.6 years. CMD‐assessed patients were more likely to be female (66.5% vs. 45.2%, p < 0.001) and have hypertension (80.2% vs. 44.5%, p < 0.001), history of stroke (11.9% vs. 6.3%, p = 0.002), and history of myocardial infarction (20.3% vs. 7.7%, p < 0.001). CMD assessment was safe, without any reported adverse outcomes. A propensity‐matched analysis showed that patients who underwent CMD assessment had slightly higher median contrast exposure (50 vs. 40 mL, p < 0.001), and slightly longer fluoroscopy time (6.9 vs. 4.7 min, p < 0.001). However, there was no difference in radiation dose (209.3 vs. 219 mGy, p = 0.58) and overall procedure time (31 vs. 29 min, p = 0.37).
Conclusion
Compared to DLHC, CMD assessment is safe and requires only slightly additional contrast use (10 mL) and slightly longer fluoroscopy time (2 min) without clinical implications. These findings emphasize the favorable safety and feasibility of invasive CMD assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia, USA.
- Division of Cardiology, NYU Langone Hospital-Long Island, Mineola, New York, USA.
ORCID-Profile: Ryan Wallace, Giorgio A Medranda, Ron Waksman
Förderung
- MedStar Health Research Institute
Zitieren
APA
Merdler, I., Wallace, R., Banerjee, A., Medranda, G. A., Reddy, P., Cellamare, M., Zhang, C., Ozturk, S. T., Sawant, V., Lopez, K., Ben-Dor, I., Waksman, R., Case, B. C., & Hashim, H. D. (2024). Coronary microvascular dysfunction assessment: A comparative analysis of procedural aspects. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.30990
Vancouver
Merdler I, Wallace R, Banerjee A, Medranda GA, Reddy P, Cellamare M, et al. Coronary microvascular dysfunction assessment: A comparative analysis of procedural aspects. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.30990
BibTeX
@article{Merdler2024,
author = {Merdler, Ilan and Wallace, Ryan and Banerjee, Avantika and Medranda, Giorgio A and Reddy, Pavan and Cellamare, Matteo and Zhang, Cheng and Ozturk, Sevket Tolga and Sawant, Vaishnavi and Lopez, Kassandra and Ben-Dor, Itsik and Waksman, Ron and Case, Brian C and Hashim, Hayder D},
title = {Coronary microvascular dysfunction assessment: A comparative analysis of procedural aspects},
journal = {Catheterization and Cardiovascular Interventions},
year = {2024},
doi = {10.1002/ccd.30990}
}
EUVIMED